MURTAZA SINGAPOREWALA: Open Payments
NPI 1427055698 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$197 in 7 payments from 6 companies in 2025. Trend: 2023 $941 · 2024 $571 · 2025 $197
Food & beverage: $197
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $60 |
| ABBVIE INC. | 1 | $34 |
| Incyte Corporation | 1 | $30 |
| Genentech USA, Inc. | 1 | $26 |
| BeOne Medicines USA, Inc. | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $23 |
Products named: Fabhalta, EPKINLY, JAKAFI, Venclexta, TEVIMBRA, TALVEY, SCEMBLIX.
Industry payments across NY — which companies pay providers there.
